1. Bell, SC, Mall, MA, Gutierrez, H, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med 2020; 8(1): 65–124. DOI: 10.1016/S2213-2600(19)30337-6.
Google Scholar | Crossref | Medline2. Que, C., Cullinan, P, Geddes, D. Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax 2006; 61(2): 155–157. DOI: 10.1136/thx.2005.043372.
Google Scholar | Crossref | Medline3. Kent, L, Reix, P, Innes, JA, et al. Lung clearance index: evidence for use in clinical trials in cystic fibrosis. J Cystic Fibrosis 2014; 13(2): 123–138. DOI: 10.1016/j.jcf.2013.09.005.
Google Scholar | Crossref | Medline4. Gee, L., Abbott, J, Conway, SP, et al. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000; 55: 946–954. DOI: 10.1136/thorax.55.11.946.
Google Scholar | Crossref | Medline5. Henry, B, Aussage, P, Grosskopf, C, et al. Development of the cystic fibrosis questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res 2003; 12: 63–76. DOI: 10.1023/a:1022037320039.
Google Scholar | Crossref | Medline | ISI6. Quittner, AL, Buu, A, Messer, MA, et al. Development and validation of the cystic fibrosis questionnaire in the United States. Chest 2005; 128(4): 2347–2354. DOI: 10.1378/chest.128.4.2347.
Google Scholar | Crossref | Medline | ISI7. Moss, RB, Flume, PA, Elborn, JS, et al. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial. Lancet Respir Med 2015; 3(7): 524–533. DOI: 10.1016/S2213-2600(15)00201-5.
Google Scholar | Crossref | Medline8. Heijerman, HGM, McKone, EF, Downey, DG, et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Lancet (London, England) 2019; 394(19): 1940–1948. DOI: 10.1016/S0140-6736(19)32597-8. pii: S0140-6736.
Google Scholar | Crossref | Medline9. Jones, PW, Quirk, FH, Baveystock, CM, et al. A self-complete measure of health status for chronic airflow limitation: the st. george's respiratory questionnaire. Am Rev Respir Dis 1992; 145: 1321–1327. DOI: 10.1164/ajrccm/145.6.1321.
Google Scholar | Crossref | Medline | ISI10. Birring, SS, Prudon, B, Carr, AJ, et al. Development of a symptom specific health status measure for patients with chronic cough: leicester cough questionnaire (LCQ). Thorax 2003; 58: 339–343. DOI: 10.1136/thorax.58.4.339.
Google Scholar | Crossref | Medline | ISI11. Padilla, A, Olveira, G, Olveira, C, et al. Validity and reliability of the St George’s respiratory questionnaire in adults with cystic fibrosis. Archivos de Bronconeumología ((English Edition)) 2007; 43: 205–211. DOI: 10.1016/s1579-2129(07)60052-4.
Google Scholar | Crossref | Medline12. Ward, N, Stiller, K, Rowe, H, et al. The psychometric properties of the leicester cough questionnaire and respiratory symptoms in CF tool in cystic fibrosis: a preliminary study. J Cystic Fibrosis 2017; 16(3): 425–432. DOI: 10.1016/j.jcf.2016.11.011.
Google Scholar | Crossref | Medline13. Wilson, CB, Jones, PW, O’Leary, CJ, et al. Validation of the St. George’s respiratory questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997; 156(2 Pt 1): 536–541. DOI: 10.1164/ajrccm.156.2.9607083.
Google Scholar | Crossref | Medline14. Murray, MP, Turnbull, K, MacQuarrie, S, et al. Validation of the leicester cough questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J 2009; 34: 125–131. DOI: 10.1183/09031936.00160508.
Google Scholar | Crossref | Medline | ISI15. Muñoz, G, Buxó, M, de Gracia, J, et al. Validation of a Spanish version of the leicester cough questionnaire in non-cystic fibrosis bronchiectasis. Chronic Respir Dis 2016; 13(2): 128–136. DOI: 10.1177/1479972316632005.
Google Scholar | SAGE Journals | ISI16. Fathi, H, Moon, T, Donaldson, J, et al. Cough in adult cystic fibrosis: diagnosis and response to fundoplication. Cough 2009; 5: 1. DOI: 10.1186/1745-9974-5-1
Google Scholar | Crossref | Medline17. Del Corral, T, Percegona, J, López, N, et al. Validación de la versión en español del Cuestionario de Tos Leicester en niños con fibrosis quística. Archivos de Bronconeumología 2016; 52(2): 63–69. DOI: 10.1016/j.arbres.2015.01.016.
Google Scholar | Crossref | Medline18. O’Sullivan, BP, Freedman, SD. Cystic fibrosis. Lancet 2009; 373(9678): 1891–1904. DOI: 10.1016/S0140-6736(09)60327-5.
Google Scholar | Crossref | Medline | ISI19. Goss, CH, Burns, JL. Exacerbations in cystic fibrosis 1: epidemiology and pathogenesis. Thorax 2007; 62: 360–367. DOI: 10.1136/thx.2006.060889.
Google Scholar | Crossref | Medline | ISI20. Aaronson, N, Alonso, J, Burnam, A, et al. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11(3): 193–205, DOI: 10.1023/a:1015291021312.
Google Scholar | Crossref | Medline21. Brooks, SM . Divisions. Europhysics News 1982; 13: 12.
Google Scholar | Crossref22. Murray, MP, Pentland, JL, Turnbull, K, et al. Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur Respir J 2009; 34: 361–364. DOI: 10.1183/09031936.00163208.
Google Scholar | Crossref | Medline | ISI23. Raj, AA, Pavord, DI, Birring, SS. Clinical cough IV:what is the minimal important difference for the leicester cough questionnaire?. Pharmacol Ther Cough 2009; 187: 311–320. DOI: 10.1007/978-3-540-79842-2_16.
Google Scholar | Crossref24. Jones, PW . Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398–404. DOI: 10.1183/09031936.02.00063702
Google Scholar | Crossref | Medline | ISI25. Bonett, DG . Sample size requirements for testing and estimating coefficient alpha. J Educ Behav Stat 2002; 27: 335–340. DOI: 10.3102/10769986027004335
Google Scholar | SAGE Journals | ISI26. Kirshner, B, Guyatt, G. A methodological framework for assessing health indices. J Chronic Dis 1985; 38: 27–36. DOI: 10.1016/0021-9681(85)90005-0.
Google Scholar | Crossref | Medline27. McGraw, KO, Wong, SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996; 1: 30–46. DOI: 10.1037/1082-989X.1.1.30
Google Scholar | Crossref28. Martin Bland, J, Altman, D. Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet 1986; 327: 307–310.
Google Scholar | Crossref29. Cohen, J . Statistical Power Analysis for the Behavioural Sciences. 2nd ed.. New Jersey: Lawrence Erlbaum, 1988.
Google Scholar30. Olveira, G, Olveira, C, Gaspar, I, et al. Validation of the spanish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQR 14+ Spain). Archivos de Bronconeumología ((English Edition)) 2010; 46: 165–175. DOI: 10.1016/j.arbres.2010.01.006.
Google Scholar | Crossref | Medline